Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Prostate cancer is a global health problem, but incidence varies considerably across
different continents. Asia is traditionally considered a low-incidence area, but the incidence …

Background High rates of overdiagnosis are a critical barrier to organized prostate cancer
screening. Magnetic resonance imaging (MRI) with targeted biopsy has shown the potential …

Monitoring survival of cancer patients using data collected by population‐based cancer
registries is an important component of cancer control. In this setting, patient survival is often …

Background Lynch syndrome is a rare familial cancer syndrome caused by pathogenic
variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause …

There is a urgent need for valuable strategy in early and less invasive diagnosis for cancer.
Preliminary data have shown that the plasmatic levels of exosomes increase in cancer …

Ferroptosis, an iron-dependent form of selective cell death, is involved in the development of
many cancers. However, ferroptosis related genes (FRGs) in prostate cancer (PCa) are not …

The detection of cancer at an early stage while it is curable by surgical resection is widely
believed to be one of the most effective strategies for reducing cancer mortality. Hence, the …

Importance If magnetic resonance imaging (MRI) mitigates overdiagnosis of prostate cancer
while improving the detection of clinically significant cases, including MRI in a screening …

Screening with a prostate-specific antigen (PSA) test could reduce death from prostate
cancer in some men but at the cost of substantial numbers overdiagnosed, as well as false …